View in EDS PDF Full Text

Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities.

Saved in:
Bibliographic Details
Title: Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities.
Authors: Estadt, Angela T.1 (AUTHOR) estadt.24@osu.edu, Kline, David2 (AUTHOR), Miller, William C.3 (AUTHOR), Feinberg, Judith4 (AUTHOR), Hurt, Christopher B.5 (AUTHOR), Mixson, L. Sarah6 (AUTHOR), Friedmann, Peter D.7 (AUTHOR), Lowe, Kelsa8 (AUTHOR), Tsui, Judith I.9 (AUTHOR), Young, April M.10 (AUTHOR), Cooper, Hannah11 (AUTHOR), Korthuis, P. Todd12 (AUTHOR), Pho, Mai T.13 (AUTHOR), Jenkins, Wiley14 (AUTHOR), Westergaard, Ryan P.8 (AUTHOR), Go, Vivian F.15 (AUTHOR), Brook, Daniel16 (AUTHOR), Smith, Gordon17 (AUTHOR), Rice, Dylan R.18 (AUTHOR), Lancaster, Kathryn E.19 (AUTHOR)
Source: Harm Reduction Journal. 11/29/2024, Vol. 21 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Description
ISSN:14777517
DOI:10.1186/s12954-024-01131-6